Loading...

U.S. Physical Therapy

DB:UPH
Snowflake Description

Excellent balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
UPH
DB
$1B
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The last earnings update was 102 days ago. More info.


Add to Portfolio Compare Print
UPH Share Price and Events
7 Day Returns
-0.1%
DB:UPH
3.9%
DE Healthcare
3%
DE Market
1 Year Returns
57.2%
DB:UPH
-24.2%
DE Healthcare
-12.1%
DE Market
UPH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
U.S. Physical Therapy (UPH) -0.1% -1.5% -8.1% 57.2% 116.2% 298.7%
DE Healthcare 3.9% 10.7% -7.6% -24.2% -13.7% 22.7%
DE Market 3% 2.8% -0.7% -12.1% 11.8% 4.9%
1 Year Return vs Industry and Market
  • UPH outperformed the Healthcare industry which returned -24.2% over the past year.
  • UPH outperformed the Market in Germany which returned -12.1% over the past year.
Price Volatility
UPH
Industry
5yr Volatility vs Market

Value

 Is U.S. Physical Therapy undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of U.S. Physical Therapy to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for U.S. Physical Therapy.

DB:UPH Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:UPH
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 9.8%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.57
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.569 (1 + (1- 21%) (4.18%))
0.588
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.8 * 9.77%)
8.05%

Discounted Cash Flow Calculation for DB:UPH using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for U.S. Physical Therapy is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:UPH DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (USD, Millions) 50.42 62.09 68.73 76.07 84.20
Source Analyst x2 Analyst x1 Est @ 10.69% Est @ 10.69% Est @ 10.69%
Present Value
Discounted (@ 8.05%)
46.66 53.19 54.49 55.82 57.19
Present value of next 5 years cash flows $267.35
DB:UPH DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= $84.20 × (1 + 0.23%) ÷ (8.05% – 0.23%)
$1,079.57
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= $1,079.57 ÷ (1 + 8.05%)5
$733.19
DB:UPH Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= $267.35 + $733.19
$1,000.54
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,000.54 / 12.68
$66.91
DB:UPH Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:UPH represents 0.84823x of NYSE:USPH
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.84823x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 78.88 x 0.84823
€66.91
Value per share (EUR) From above. €66.91
Current discount Discount to share price of €95.07
= -1 x (€95.07 - €66.91) / €66.91
-42.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of U.S. Physical Therapy is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for U.S. Physical Therapy's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are U.S. Physical Therapy's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:UPH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in USD $1.45
NYSE:USPH Share Price ** NYSE (2019-02-15) in USD $112.08
Germany Healthcare Industry PE Ratio Median Figure of 10 Publicly-Listed Healthcare Companies 20.43x
Germany Market PE Ratio Median Figure of 419 Publicly-Listed Companies 18.21x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of U.S. Physical Therapy.

DB:UPH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NYSE:USPH Share Price ÷ EPS (both in USD)

= 112.08 ÷ 1.45

77.28x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • U.S. Physical Therapy is overvalued based on earnings compared to the DE Healthcare industry average.
  • U.S. Physical Therapy is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does U.S. Physical Therapy's expected growth come at a high price?
Raw Data
DB:UPH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 77.28x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
17.1%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.69x
Germany Market PEG Ratio Median Figure of 276 Publicly-Listed Companies 1.42x

*Line of best fit is calculated by linear regression .

DB:UPH PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 77.28x ÷ 17.1%

4.53x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • U.S. Physical Therapy is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on U.S. Physical Therapy's assets?
Raw Data
DB:UPH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in USD $16.70
NYSE:USPH Share Price * NYSE (2019-02-15) in USD $112.08
Germany Healthcare Industry PB Ratio Median Figure of 12 Publicly-Listed Healthcare Companies 1.44x
Germany Market PB Ratio Median Figure of 566 Publicly-Listed Companies 1.79x
DB:UPH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NYSE:USPH Share Price ÷ Book Value per Share (both in USD)

= 112.08 ÷ 16.70

6.71x

* Primary Listing of U.S. Physical Therapy.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • U.S. Physical Therapy is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess U.S. Physical Therapy's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. U.S. Physical Therapy has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is U.S. Physical Therapy expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
17.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is U.S. Physical Therapy expected to grow at an attractive rate?
  • U.S. Physical Therapy's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • U.S. Physical Therapy's earnings growth is expected to exceed the Germany market average.
  • U.S. Physical Therapy's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:UPH Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:UPH Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts 17.1%
DB:UPH Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 6.4%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 2.4%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 4.7%
Germany Market Earnings Growth Rate Market Cap Weighted Average 9.6%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:UPH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:UPH Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 514 75 39 4
2019-12-31 481 68 36 6
2018-12-31 453 68 32 6
DB:UPH Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-09-30 442 70 18
2018-06-30 432 65 22
2018-03-31 421 58 21
2017-12-31 410 57 22
2017-09-30 392 53 20
2017-06-30 377 42 20
2017-03-31 363 51 21
2016-12-31 353 51 21
2016-09-30 348 48 20
2016-06-30 344 49 21
2016-03-31 337 49 21
2015-12-31 327 38 21

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • U.S. Physical Therapy's earnings are expected to grow by 17.1% yearly, however this is not considered high growth (20% yearly).
  • U.S. Physical Therapy's revenue is expected to grow by 6.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:UPH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from U.S. Physical Therapy Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:UPH Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 3.07 3.25 2.80 4.00
2019-12-31 2.80 2.90 2.65 4.00
2018-12-31 2.55 2.57 2.52 3.00
DB:UPH Past Financials Data
Date (Data in USD Millions) EPS *
2018-09-30 1.45
2018-06-30 1.73
2018-03-31 1.64
2017-12-31 1.76
2017-09-30 1.61
2017-06-30 1.58
2017-03-31 1.67
2016-12-31 1.64
2016-09-30 1.60
2016-06-30 1.69
2016-03-31 1.68
2015-12-31 1.66

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • U.S. Physical Therapy is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess U.S. Physical Therapy's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
U.S. Physical Therapy has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has U.S. Physical Therapy performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare U.S. Physical Therapy's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • U.S. Physical Therapy's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • U.S. Physical Therapy's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • U.S. Physical Therapy's 1-year earnings growth is negative, it can't be compared to the DE Healthcare industry average.
Earnings and Revenue History
U.S. Physical Therapy's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from U.S. Physical Therapy Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:UPH Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 441.71 18.34 41.12
2018-06-30 431.58 21.79 38.78
2018-03-31 420.99 20.68 37.51
2017-12-31 410.38 22.13 35.89
2017-09-30 391.92 20.15 33.55
2017-06-30 377.24 19.81 32.85
2017-03-31 363.35 20.88 32.02
2016-12-31 352.51 20.55 32.48
2016-09-30 348.39 20.01 33.53
2016-06-30 343.95 21.02 32.85
2016-03-31 336.70 20.94 32.41
2015-12-31 327.13 20.62 31.07
2015-09-30 319.83 20.89 30.36
2015-06-30 313.48 20.29 30.90
2015-03-31 308.40 19.71 30.92
2014-12-31 300.96 19.13 30.40
2014-09-30 290.20 18.69 28.98
2014-06-30 278.31 18.20 27.74
2014-03-31 266.83 18.04 26.65
2013-12-31 259.67 17.73 25.93
2013-09-30 253.26 18.11 25.24
2013-06-30 249.38 18.05 24.93
2013-03-31 245.02 17.80 24.66
2012-12-31 244.83 18.36 24.50
2012-09-30 243.08 22.30 25.51
2012-06-30 240.48 21.74 24.75
2012-03-31 238.57 21.71 24.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • U.S. Physical Therapy has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • U.S. Physical Therapy used its assets more efficiently than the DE Healthcare industry average last year based on Return on Assets.
  • U.S. Physical Therapy's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess U.S. Physical Therapy's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
U.S. Physical Therapy has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is U.S. Physical Therapy's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up U.S. Physical Therapy's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • U.S. Physical Therapy is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • U.S. Physical Therapy's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of U.S. Physical Therapy's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from U.S. Physical Therapy Company Filings, last reported 4 months ago.

DB:UPH Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 342.00 59.43 32.24
2018-06-30 329.78 61.42 27.15
2018-03-31 316.57 48.10 19.81
2017-12-31 308.97 60.77 21.93
2017-09-30 296.33 62.70 17.42
2017-06-30 291.55 75.70 20.24
2017-03-31 272.87 64.02 25.15
2016-12-31 257.88 51.82 20.05
2016-09-30 227.07 41.53 15.02
2016-06-30 223.05 48.09 20.45
2016-03-31 217.04 58.37 19.21
2015-12-31 218.28 49.11 15.78
2015-09-30 195.14 49.09 20.56
2015-06-30 192.60 42.86 12.97
2015-03-31 183.57 42.92 14.56
2014-12-31 174.59 35.62 14.27
2014-09-30 170.56 47.80 15.82
2014-06-30 165.39 46.30 12.93
2014-03-31 157.29 46.73 16.76
2013-12-31 155.12 41.48 12.90
2013-09-30 146.71 15.13 12.12
2013-06-30 147.23 16.95 10.29
2013-03-31 139.68 21.38 10.28
2012-12-31 134.66 18.03 11.67
2012-09-30 136.39 16.88 10.68
2012-06-30 132.57 20.88 8.81
2012-03-31 125.84 25.02 10.44
  • U.S. Physical Therapy's level of debt (17.4%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (10.5% vs 17.4% today).
  • Debt is well covered by operating cash flow (117.3%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 6.8x coverage).
X
Financial health checks
We assess U.S. Physical Therapy's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. U.S. Physical Therapy has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is U.S. Physical Therapy's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.82%
Current annual income from U.S. Physical Therapy dividends. Estimated to be 1% next year.
If you bought €2,000 of U.S. Physical Therapy shares you are expected to receive €16 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • U.S. Physical Therapy's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.53%).
  • U.S. Physical Therapy's dividend is below the markets top 25% of dividend payers in Germany (3.96%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:UPH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 1.6%
Germany Market Average Dividend Yield Market Cap Weighted Average of 332 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 4%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:UPH Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 1.20 1.00
2019-12-31 1.04 1.00
2018-12-31 0.92 1.00
DB:UPH Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2018-11-07 0.920 0.844
2018-11-01 0.920 0.802
2018-05-03 0.920 0.871
2018-03-08 0.920 1.068
2017-11-02 0.800 1.095
2017-08-03 0.800 1.297
2017-05-31 0.800 1.271
2017-03-31 0.800 1.245
2016-11-03 0.680 0.998
2016-08-05 0.680 1.100
2016-08-04 0.680 1.114
2016-03-03 0.680 1.244
2015-11-05 0.600 1.183
2015-08-06 0.600 1.269
2015-05-07 0.600 1.158
2015-03-12 0.600 1.256
2015-03-05 0.600 1.317
2014-11-07 0.480 1.194
2014-11-06 0.480 1.207
2014-05-08 0.480 1.372
2014-03-06 0.480 1.473
2013-11-07 0.400 1.215
2013-08-08 0.400 1.306
2013-05-09 0.400 1.393
2013-03-07 0.400 1.644
2012-11-08 0.360 1.400
2012-08-09 0.360 1.352
2012-05-03 0.360 1.448
2012-03-08 0.360 1.601
2011-11-03 0.320 1.641
2011-08-04 0.320 1.667
2011-05-05 0.320 1.332
2011-03-03 0.320 1.436

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • U.S. Physical Therapy is not paying a notable dividend for Germany, therefore no need to check if the payments are stable.
  • U.S. Physical Therapy is not paying a notable dividend for Germany, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of U.S. Physical Therapy's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of U.S. Physical Therapy's dividends as it is not paying a notable one for Germany.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.6x coverage).
X
Income/ dividend checks
We assess U.S. Physical Therapy's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can U.S. Physical Therapy afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. U.S. Physical Therapy has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of U.S. Physical Therapy's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Chris Reading
COMPENSATION $2,476,858
AGE 54
TENURE AS CEO 14.3 years
CEO Bio

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer and President of US Physical Therapy Inc. since November 1, 2004. Mr. Reading served as the Chief Operating Officer at Us Physical Therapy Inc. from October 10, 2003 to January 2005. He served as Senior Vice President of Operations at HealthSouth Corporation, where he was responsible for over 200 facilities located in 10 states. Mr. Reading has been a Director of US Physical Therapy Inc. since November 1, 2004. Mr. Reading holds a Bachelor of Science degree in Physical Therapy with high honors from the Medical College of Virginia.

CEO Compensation
  • Chris's compensation has increased by more than 20% in the past year.
  • Chris's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the U.S. Physical Therapy management team in years:

14.1
Average Tenure
57.5
Average Age
  • The average tenure for the U.S. Physical Therapy management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Chris Reading

TITLE
President
COMPENSATION
$2M
AGE
54
TENURE
14.3 yrs

Larry McAfee

TITLE
Executive VP
COMPENSATION
$1M
AGE
63
TENURE
15.4 yrs

Glenn McDowell

TITLE
Chief Operating Officer of West
COMPENSATION
$1M
AGE
61
TENURE
14.1 yrs

Graham Reeve

TITLE
Chief Operating Officer of East
AGE
54
TENURE
0.9 yrs

Jon Bates

TITLE
VP & Corporate Controller
TENURE
12.3 yrs

Rick Binstein

TITLE
Secretary

Johnny Blanchard

TITLE
Assistant Controller
Board of Directors Tenure

Average tenure and age of the U.S. Physical Therapy board of directors in years:

12.5
Average Tenure
66
Average Age
  • The average tenure for the U.S. Physical Therapy board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Jerry Pullins

TITLE
Chairman of the Board
COMPENSATION
$236K
AGE
76
TENURE
7.8 yrs

Chris Reading

TITLE
President
COMPENSATION
$2M
AGE
54
TENURE
14.3 yrs

Larry McAfee

TITLE
Executive VP
COMPENSATION
$1M
AGE
63
TENURE
14.3 yrs

Clayton Trier

TITLE
Independent Director
COMPENSATION
$199K
AGE
66
TENURE
14 yrs

Harry Chapman

TITLE
Independent Director
COMPENSATION
$191K
AGE
73
TENURE
8.5 yrs

Eddie Kuntz

TITLE
Independent Director
COMPENSATION
$183K
AGE
73
TENURE
4.5 yrs

Mark Brookner

TITLE
Independent Director
COMPENSATION
$176K
AGE
73
TENURE
20.5 yrs

Bernard Harris

TITLE
Independent Director
COMPENSATION
$178K
AGE
61
TENURE
13.5 yrs

Regg Swanson

TITLE
Director
COMPENSATION
$111K
AGE
64
TENURE
11.4 yrs

Kathleen Gilmartin

TITLE
Director
AGE
66
TENURE
0.8 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by U.S. Physical Therapy insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
27. Dec 18 Buy Reginald Swanson Individual 26. Dec 18 26. Dec 18 500 €88.70 €44,338
13. Dec 18 Buy Harry Chapman Individual 11. Dec 18 11. Dec 18 1,200 €97.75 €117,300
20. Nov 18 Sell Mark Brookner Individual 16. Nov 18 16. Nov 18 -500 €103.91 €-51,956
06. Nov 18 Sell Lawrance McAfee Individual 02. Nov 18 02. Nov 18 -3,100 €99.51 €-308,493
06. Nov 18 Sell Mark Brookner Individual 05. Nov 18 05. Nov 18 -2,000 €99.76 €-199,518
24. Sep 18 Sell Mark Brookner Individual 21. Sep 18 21. Sep 18 -2,500 €98.73 €-246,819
10. Sep 18 Sell Mark Brookner Individual 07. Sep 18 07. Sep 18 -625 €110.97 €-69,358
24. Aug 18 Sell Mark Brookner Individual 23. Aug 18 23. Aug 18 -4,375 €100.96 €-441,574
20. Aug 18 Sell Clayton Trier Individual 17. Aug 18 17. Aug 18 -1,250 €101.20 €-126,501
15. Aug 18 Sell Christopher Reading Individual 14. Aug 18 14. Aug 18 -8,768 €101.76 €-892,226
08. Aug 18 Sell Christopher Reading Individual 06. Aug 18 07. Aug 18 -1,232 €100.59 €-123,610
08. Aug 18 Sell Jerald Pullins Individual 06. Aug 18 06. Aug 18 -4,000 €99.40 €-397,613
06. Aug 18 Sell Glenn McDowell Individual 03. Aug 18 03. Aug 18 -6,204 €98.98 €-614,058
06. Aug 18 Sell Lawrance McAfee Individual 03. Aug 18 03. Aug 18 -3,100 €99.65 €-308,915
17. May 18 Sell Mark Brookner Individual 16. May 18 16. May 18 -1,250 €77.92 €-97,397
14. May 18 Sell Edward Kuntz Individual 11. May 18 11. May 18 -2,000 €77.09 €-154,189
11. May 18 Sell Christopher Reading Individual 09. May 18 11. May 18 -25,000 €77.21 €-1,927,776
15. Mar 18 Sell Glenn McDowell Individual 14. Mar 18 15. Mar 18 -4,079 €67.59 €-274,006
14. Mar 18 Sell Glenn McDowell Individual 12. Mar 18 13. Mar 18 -2,743 €69.53 €-190,606
13. Mar 18 Sell Lawrance McAfee Individual 12. Mar 18 12. Mar 18 -2,000 €69.89 €-139,779
13. Mar 18 Sell Jerald Pullins Individual 09. Mar 18 09. Mar 18 -6,100 €70.24 €-428,439
13. Mar 18 Sell Christopher Reading Individual 09. Mar 18 09. Mar 18 -12,000 €70.26 €-843,123
13. Mar 18 Sell Bernard Harris Individual 09. Mar 18 12. Mar 18 -6,000 €70.29 €-421,604
12. Mar 18 Sell Lawrance McAfee Individual 09. Mar 18 09. Mar 18 -5,000 €67.65 €-338,234
X
Management checks
We assess U.S. Physical Therapy's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. U.S. Physical Therapy has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Map
Description

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

Details
Name: U.S. Physical Therapy, Inc.
UPH
Exchange: DB
Founded: 1990
$1,261,055,106
12,684,762
Website: http://www.usph.com
Address: U.S. Physical Therapy, Inc.
1300 West Sam Houston Parkway South,
Suite 300,
Houston,
Texas, 77042,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NYSE USPH Common Stock New York Stock Exchange US USD 28. May 1992
DB UPH Common Stock Deutsche Boerse AG DE EUR 28. May 1992
Number of employees
Current staff
Staff numbers
3,650
U.S. Physical Therapy employees.
Industry
Health Care Facilities
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/17 22:12
End of day share price update: 2019/02/15 00:00
Last estimates confirmation: 2018/12/18
Last earnings filing: 2018/11/07
Last earnings reported: 2018/09/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.